scispace - formally typeset
A

Antonio Antela

Researcher at University of Alcalá

Publications -  108
Citations -  4336

Antonio Antela is an academic researcher from University of Alcalá. The author has contributed to research in topics: Ritonavir & Viral load. The author has an hindex of 28, co-authored 101 publications receiving 3774 citations.

Papers
More filters
Journal ArticleDOI

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

Alison Rodger, +168 more
- 15 Jun 2019 - 
TL;DR: The results suggest that the risk of HIV transmission in gay couples through condomless sex when HIV viral load is suppressed is effectively zero, which supports the message of the U=U (undetectable equals untransmittable) campaign, and the benefits of early testing and treatment for HIV.
Journal ArticleDOI

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study.

TL;DR: In patients with sustained virological suppression on ritonavir-boosted protease inhibitor-based therapy, switching to raltegravir demonstrated noninferior efficacy and resulted in a better lipid profile at 48 weeks than continuing riton Cavir- boosted protease inhibitors.
Journal ArticleDOI

Influence of Liver Fibrosis on Highly Active Antiretroviral Therapy-Associated Hepatotoxicity in Patients With HIV and Hepatitis C Virus Coinfection

TL;DR: HAART-associated hepatotoxicity correlates with liver histological stage in patients coinfected with HIV and HCV, and there was no difference in hepatot toxicity risk for different antiretroviral therapies in patients with mild-to-moderate fibrosis.
Journal ArticleDOI

Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients

TL;DR: The use of the most potent antiretroviral therapy in pretreated patients with high HIV load, and the capacity of initial virological decline to predict the long-term outcome are suggested.